FRIDAY, April 15, 2022 (HealthDay News) — Disability activist Gem Hubbard regularly shares her insights about life in a wheelchair with more than 75,000 Instagram followers, under the handle @wheelsnoheels_, and her YouTube videos boast more than 3.7 million hits. Hubbard, who hails from the U.K., is “increasingly known internationallyContinue Reading

THURSDAY, April 14, 2022 (HealthDay News) — While the vast majority of dental implant procedures go smoothly, related infections can up the risk for implant failure. Antibiotics can keep that risk at bay, with penicillin the typical go-to choice. But new research warns that when patients are given an alternativeContinue Reading

THURSDAY, April 14, 2022 (HealthDay News) — America’s public health emergency plan for COVID-19 will continue for at least another 90 days, the Biden administration announced Wednesday. Pushing the deadline to mid-July means that vulnerable Americans will keep getting the health care benefits the program offers. The emergency plan hasContinue Reading

WEDNESDAY, April 13, 2022 (HealthDay News) — Rates of gonorrhea are on the rise, and this sexually transmitted disease is becoming increasingly resistant to antibiotics, raising fears of a potential superbug. Luckily, while there isn’t a vaccine against gonorrhea yet, an available meningitis vaccine may offer some protection against thisContinue Reading

TUESDAY, April 12, 2022 (HealthDay News) — Psilocybin — the active component in “magic mushrooms” — may help rewire the brains of people with depression. Psychedelics including psilocybin have shown promise in treating many mental health disorders in recent years, and a new study is among the first to beginContinue Reading

TUESDAY, April 12, 2022 (HealthDay News) — Faced with rising COVID-19 case counts, Philadelphia has announced that it will reinstate an indoor mask mandate next week. City officials announced the change on Monday, as COVID-19 cases have climbed across the country due to the highly transmissible Omicron subvariant known asContinue Reading

TUESDAY, April 12, 2022 (HealthDay News) — A single dose of human papillomavirus (HPV) vaccine provides as much protection against cervical cancer as the standard three-dose regimen, a new study finds. “These findings are a game-changer that may substantially reduce the incidence of HPV-attributable cervical cancer, and positions single-dose HPVContinue Reading